Ming-Sen Dai1, Ke-Wei Hu1, Wei Wu1, Guo-Jian Yin1, Duan-Min Hu2. 1. Department of Gastroenterology, The Second Affiliated Hospital of Soochow University, Suzhou, 215000, Jiangsu, China. 2. Department of Gastroenterology, The Second Affiliated Hospital of Soochow University, Suzhou, 215000, Jiangsu, China. huduanmins@126.com.
Abstract
BACKGROUND: There are many studies on submucosal injection materials, but their clinical use is restricted for various reasons. The objective of this study was to compare the feasibility and safety of injected EndoClot®SIS polysaccharide as a submucosal injection material (SFC) in ESD in the pig stomach to that of injected sigMAVisc™ or Eleview™. METHODS: Four pig stomachs were used for the ex vivo study. Eighteen pigs were used for the in vivo study. In the ex vivo study, four injections were made in the gastric submucosa to induce submucosal uplift and extend its duration. Tissue change was observed. The in vivo study was performed in 2 steps. First, 3 injections were made in the esophageal mucosa to induce submucosal uplift and extend its duration. Histological change was observed. Second, ESD was performed in the stomach by injecting EndoClot®SIS polysaccharide, sigMAVisc™, or Eleview™ (each, n = 6) as an SFC. The effects of these agents on wound healing were examined. We evaluated the efficacy and safety of endoscopic surgery after EndoClot®SIS polysaccharide injection. RESULTS: EndoClot®SIS polysaccharide produced a longer-lasting elevation with clearer margins than was achieved by sigMAVisc™, Eleview™, or 0.9% NaCl and thereby enabled precise ESD without complications, such as bleeding and perforation. No obvious histopathological damage was observed at the injection site on endoscopy and histology. CONCLUSION: Submucosally injected EndoClot®SIS polysaccharide increased the effective separation of the mucosa and submucosa and reduced surgical complications. Hence, EndoClot®SIS polysaccharide injection is a safe and effective submucosal injection material.
BACKGROUND: There are many studies on submucosal injection materials, but their clinical use is restricted for various reasons. The objective of this study was to compare the feasibility and safety of injected EndoClot®SIS polysaccharide as a submucosal injection material (SFC) in ESD in the pig stomach to that of injected sigMAVisc™ or Eleview™. METHODS: Four pig stomachs were used for the ex vivo study. Eighteen pigs were used for the in vivo study. In the ex vivo study, four injections were made in the gastric submucosa to induce submucosal uplift and extend its duration. Tissue change was observed. The in vivo study was performed in 2 steps. First, 3 injections were made in the esophageal mucosa to induce submucosal uplift and extend its duration. Histological change was observed. Second, ESD was performed in the stomach by injecting EndoClot®SIS polysaccharide, sigMAVisc™, or Eleview™ (each, n = 6) as an SFC. The effects of these agents on wound healing were examined. We evaluated the efficacy and safety of endoscopic surgery after EndoClot®SIS polysaccharide injection. RESULTS: EndoClot®SIS polysaccharide produced a longer-lasting elevation with clearer margins than was achieved by sigMAVisc™, Eleview™, or 0.9% NaCl and thereby enabled precise ESD without complications, such as bleeding and perforation. No obvious histopathological damage was observed at the injection site on endoscopy and histology. CONCLUSION: Submucosally injected EndoClot®SIS polysaccharide increased the effective separation of the mucosa and submucosa and reduced surgical complications. Hence, EndoClot®SIS polysaccharide injection is a safe and effective submucosal injection material.
Entities:
Keywords:
EUS; Endoscopic submucosal dissection; Experiments on animals; Submucosal injection
Authors: H Yamamoto; H Koiwai; T Yube; N Isoda; Y Sato; Y Sekine; T Higashizawa; K Utsunomiya; K Ido; K Sugano Journal: Gastrointest Endosc Date: 1999-11 Impact factor: 9.427
Authors: Jong Jin Hyun; Hwang Rae Chun; Hoon Jai Chun; Yoon Tae Jeen; Chang Won Baeck; Sang Kyun Yu; Yong Sik Kim; Hong Sik Lee; Soon Ho Um; Sang Woo Lee; Jai Hyun Choi; Chang Duck Kim; Ho Sang Ryu; Jin Hai Hyun Journal: Scand J Gastroenterol Date: 2006-04 Impact factor: 2.423
Authors: H Yamamoto; T Yube; N Isoda; Y Sato; Y Sekine; T Higashizawa; K Ido; K Kimura; N Kanai Journal: Gastrointest Endosc Date: 1999-08 Impact factor: 9.427
Authors: Massimo Conio; Elizabeth Rajan; Darius Sorbi; Ian Norton; Lori Herman; Rosangela Filiberti; Christopher J Gostout Journal: Gastrointest Endosc Date: 2002-10 Impact factor: 9.427
Authors: M Fujishiro; N Yahagi; K Kashimura; Y Mizushima; M Oka; S Enomoto; N Kakushima; K Kobayashi; T Hashimoto; M Iguchi; Y Shimizu; M Ichinose; M Omata Journal: Endoscopy Date: 2004-07 Impact factor: 10.093